Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigamox for Prevention of Postcataract Endophthalmitis
NCT02595359Phase 2Completed
- Sponsor
- Universidade Federal de Pernambuco
- Start
- Jan 2013
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of moxifloxacin in endophthalmitis, sponsored by Universidade Federal de Pernambuco. Started Jan 2013; status: completed.
02
Drugs
moxifloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT02595359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595359.